BRD4 and cancer: Despite the promising contribution of CAP to the cancer cure, less focus has been put on the role of receptors in mediating CAP’s selectivity against malignant cells, the emphasis of which may result in the clarification of this black box (i.e., CAP) from the ‘receptor’ perspective and should lead to one important future trend.